New Era Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 05-11-2024
- Paid Up Capital ₹ 1.00 M
as on 05-11-2024
- Company Age 2 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
About New Era Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Ravinder Velchala, Pratibha Velchala, and Venkata Chelikani serve as directors at the Company.
- CIN/LLPIN
U85300TG2022PTC160473
- Company No.
160473
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Mar 2022
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at New Era Diagnostics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravinder Velchala  | Director | 10-Mar-2022 | Current |
| Pratibha Velchala | Director | 10-Mar-2022 | Current |
| Venkata Chelikani | Director | Current |
Financial Performance of New Era Diagnostics.
New Era Diagnostics Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of New Era Diagnostics?
Unlock access to New Era Diagnostics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
The Federation Of Telangana Chambers Of Commerce And IndustryActive 60 years 22 daysVenkata Chelikani is a mutual person
- Craft Stone Private LimitedActive 12 years 1 month
Ravinder Velchala and Pratibha Velchala are mutual person
- Speed Projects And Infrastructure Private LimitedActive 21 years 7 months
Ravinder Velchala and Pratibha Velchala are mutual person
- Kothrepally Builders Private LimitedActive 18 years 1 month
Ravinder Velchala and Pratibha Velchala are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at New Era Diagnostics?
Unlock and access historical data on people associated with New Era Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of New Era Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped New Era Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.